Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Application
Item No. 29274

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
GABAA receptors are ligand-gated chloride channels that mediate the effects of the inhibitory neurotransmitter GABA in the CNS.1,2 They are postsynaptic heteropentameric receptors that contain protein subunits from the following isoforms: α1-6, β1-4, γ1-3, δ, ε, π, θ, and ρ1-3, arranged around a central pore. Phasic inhibitory synaptic transmission is regulated by α1β2γ2 subunit-containing GABAA receptors, the major isoform found in the brain.2,3 The β subunit of GABAA receptors interfaces with an α subunit to form the GABA binding site that initiates GABA-induced action potentials and forms the benzodiazepine binding site with the γ subunit. Phosphorylation of the β2 subunit by PKC inhibits binding of the β2 subunit with the clathrin adaptor protein AP2 and reduces GABAA receptor endocytosis.4 SNPs in GABRB2, which encodes the β2 subunit isoform, have been found in patients with schizophrenia.5 Cayman's GABAA Receptor β2 Polyclonal Antibody can be used for Western blot (WB) applications. The antibody recognizes the GABAA receptor β2 subunit at approximately 55 kDa from mouse and rat samples.
WARNING This product is not for human or veterinary use.
1. Behavioral functions of GABAA receptor subtypes -
2. Mutant GABAA receptor subunits in genetic (idiopathic) epilepsy. Genetics of epilepsy 55-85 (2014).
3. α subunits in GABAA receptors are dispensable for GABA and diazepam action. Sci. Rep. 7(1), 15498 (2017).
4. The dynamic modulation of GABAA receptor trafficking and its role in the formation of inhibitory synapses. Physiol. Rev. 91(3), 1009-1022 (2011).
5. Two isoforms of GABAA receptor β2 subunit with different electrophysiological properties: Differential expression and genotypical correlations in schizophrenia. Mol. Psychiatry 11(12), 1092-1105 (2006).